Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Nov 21, 2018; 24(43): 4950-4958
Published online Nov 21, 2018. doi: 10.3748/wjg.v24.i43.4950
Table 1 Clinical characteristics of the patients
CharacteristicCRCIS (n = 114)CRC (n = 114)P value
Age65.33 ± 12.4563.67 ± 9.180.748a
Gender
Male, n (%)78 (68.42)78 (68.42)1.000b
Female, n (%)36 (31.58)36 (31.58)
Blood tests
WBC (109/L)7.71 ± 2.277.18 ± 1.970.058a
HGB (g/L)114.96 ± 23.09122.57 ± 85.550.360a
PLT (109/L)242.28 ± 116.46235.51 ± 82.350.613a
NC (109/L)5.65 ± 2.284.16 ± 1.49< 0.001a
PT (s)10.94 ± 1.4010.82 ± 0.980.474a
INR0.95 ± 0.130.92 ± 0.080.137a
APTT (s)29.52 ± 6.7930.11 ± 6.200.496a
FIB (g/L)5.42 ± 4.425.32 ± 4.740.862a
D-dimer (μg/mL)1.40 ± 0.930.56 ± 0.47< 0.001a
CRP (mg/L)33.54 ± 35.5028.79 ± 34.380.431a
CEA (U/mL)222.31 ± 175.8588.48 ± 55.04< 0.001a
CA125 (U/mL)47.13 ± 54.3222.70 ± 34.61< 0.001a
CA199 (U/mL)293.41 ± 1428.1824.83 ± 34.2120.066a
Type of CRC
Adenocarcinoma1071100.235b
Nonadenocarcinoma74
Systemic metastasis, n (%)0.080b
Yes74 (64.9)61 (53.5)
No40 (35.1)53 (46.5)
Methods of therapy, n (%)
Surgery76 (66.7)87 (76.3)0.107b
Chemotherapy46 (40.4)33 (28.9)0.070b
No treatment28 (24.6)24 (21.2)0.528b